Prognostic groups, COO types, and survival outcomes. (A) Distributions of COO types by the Hans criteria, gene rearrangements, and protein expressions in 3 prognostic groups. (B) PFS and (C) OS curves of non-GC-type DLBCLs according to the prognostic groups. (D-E) PFS and OS curves of GC-type DLBCLs according to the prognostic groups. BCL2+, BCL2 rearrangement-positive; BCL6+, BCL6 rearrangement-positive; MYC+, MYC rearrangement-positive.